...Seattle, Wash. Business: Cancer, Inflammation Hired: Carol Gallagher as CEO, formerly president and CEO of Metastatix Inc. WIR...

...Wash.) hired Carol Gallagher as CEO. Previously, she was president and CEO of cancer company Metastatix...

...inflammation that can have pathologic consequences." Traffic jam Sofia Ribeiro, director of cell biology at Metastatix Inc....
...then restore normal T cell trafficking in the CNS would have a huge therapeutic advantage." Metastatix...
...CXCR4 antagonists when treating CNS infections. Companies and Institutions Mentioned Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. Metastatix Inc....

...I Myelopoiesis factors Prokineticin 2 (PROK2; Bv8) Genentech Antibody [Bv8] Preclinical Stromal cell-derived factor-1 (SDF-1) Metastatix Inc....

...Metastatix began an open-label, dose-escalation, U.S. Phase I trial in patients. Metastatix Inc. , Tucker, Ga. Product...

...Metastatix submitted an IND to begin a Phase I trial. Metastatix Inc. , Tucker, Ga. Product: MSX-122...

...One; MedImmune Ventures; Georgia Venture Partners; Centrosome Ventures; and the State of Georgia also participated. Metastatix's...
...inhibitor that is in preclinical development for solid tumors. Frazier's James Topper will join Metastatix's...

...Capital has already made five investments from the fund. One was an A round to Metastatix...